Trial intelligence / Profile preview

NIASTAR: Niaspan in South Asian Stroke Survivors

2005-004080-28Phase 4Completed

Sponsor
Sandwell Medical Research Unit
Start
Oct 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in stroke comparing Niaspan + simvastatin with Placebo + simvastatin (2 arms). Primary endpoints: Carotid artery intima-media thickness regression at 12 months and Carotid artery intima-media thickness regression at 24 months. Started Oct 2005; status: completed.

02

Drugs

niacin
03

Conditions

stroke

Beyond the preview

Go deeper on 2005-004080-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004080-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call